Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

STAT-CAT: Statin Therapy to Prevent Cancer Associated Venous Thromboembolism

NCT07303816 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.

NCT NCT07303816
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07303816 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
STAT-CAT: Statin Therapy to Prevent Cancer Associated Venous Thromboembolism
Lead sponsor
Brigham and Women's Hospital
Phase
Phase 4
Overall status
Recruiting
Start date
June 11, 2026
Completion date
March 31, 2032
Enrollment
4,000 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, cardiovascular events, venous thromboembolism